Metreleptin Ups Resting-State Connectivity in Lipodystrophy

This article originally appeared here.
Share this content:
Metreleptin Ups Resting-State Connectivity in Lipodystrophy
Metreleptin Ups Resting-State Connectivity in Lipodystrophy

WEDNESDAY, May 11, 2016 (HealthDay News) -- For patients with lipodystrophy (LD), resting-state connectivity is significantly increased in three brain areas with metreleptin treatment, with decreased hunger feelings and diminished incentive value of food, according to a study published online May 10 in Diabetes.

Haiko Schlögl, M.D., from the University Hospital Leipzig in Germany, and colleagues performed resting-state functional magnetic resonance imaging scans and extensive behavioral testing during the first 52 weeks of metreleptin treatment in nine patients with LD.

The researchers found that over the course of metreleptin treatment, resting-state connectivity significantly increased in three brain areas: hypothalamus, insula/superior temporal gyrus, and medial prefrontal cortex. During metreleptin therapy, behavioral tests showed that there were significant decreases in perceived hunger, importance of eating, eating frequencies, and liking ratings of food pictures.

"Taken together, leptin substitution was accompanied by long-term changes of hedonic and homeostatic central nervous networks regulating eating behavior, as well as decreased hunger feelings and diminished incentive value of food," the authors write. "It needs to be assessed in future studies whether metreleptin treatment in LD restores physiological processes important for the development of satiety."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

FDA Seeks to Increase Number of Generic Drugs on Market

FDA Seeks to Increase Number of Generic Drugs ...

Agency will now give priority reviews to new generic drugs until there are at least three available

PPIs Not Found to Raise Risk of Alzheimer's Disease

PPIs Not Found to Raise Risk of Alzheimer's ...

New research debunks other studies suggesting that PPIs cause mental decline

Aspirin Effective in Pregnancies at High Risk for Preeclampsia

Aspirin Effective in Pregnancies at High Risk for ...

Odds of preeclampsia drop for high-risk women who take 150 mg of aspirin daily, researchers find

is free, fast, and customized just for you!

Already a member?

Sign In Now »